At the EADV (European Academy of Dermatology and Venereology) congress, Charlotte van Riel, physician-researcher in the department of dermatology at Radboudumc and affiliated with the BeNeBio study, presented a poster with the baseline data of participants in the BeNeBio study.
On 14 September 2023, the last patient was included in the BeNeBio study. With this, we have achieved our goal of including 244 patients!We are very happy about this. To all centres and patients participating in the BeNeBio study: thank you very much!
On behalf of the BeNeBio study team we wish everyone a happy and healthy 2021. We will look forward to further collaborations with all involved parties, because ‘together we make BeNeBio work’!
After a delay due to COVID19, in August the first patients started with the BeNeBio study in the Radboudumc. The preparations for study start in the other participating centres are ongoing. We expect that the first patients in the other centres can be included soon!
Preparations for the start of the BeNeBio study are ongoing. Local approval from the medical ethical committee in the Netherlands is received. Local approvals for all participating sites is being requested. Due to COVID-19, the start of the study will be delayed.